JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on February 15, 2008 Originally published In Press as doi:10.1074/jbc.M707917200 on November 20, 2007
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
283/7/3997    most recent
M707917200v2
M707917200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fischer, A.
Right arrow Articles by Montal, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fischer, A.
Right arrow Articles by Montal, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print December 6, 2007
J. Biol. Chem, 10.1074/jbc.M707917200
Submitted on September 21, 2007
Revised on November 6, 2007
Accepted on November 20, 2007

Molecular architecture of Botulinum neurotoxin E revealed by single particle electron microscopy

Audrey Fischer, Consuelo Garcia-Rodriguez, Isin Geren, Jianlong Lou, James D. Marks, Terunaga Nakagawa, and Mauricio Montal

Division of Biological Sciences, Section of Neurobiology, UCSD, La Jolla, CA 92093-0366

Corresponding Author: mmontal{at}ucsd.edu

Clostridial botulinum neurotoxin (BoNT) causes a neuroparalytic condition recognized as botulism by arresting synaptic vesicle exocytosis. While the crystal structures of full-length BoNT/A and BoNT/B holotoxins are known, the molecular architecture of the five other serotypes remains elusive. Here, we present the structures of BoNT/A and BoNT/E using single-particle electron microscopy (EM). Labeling of the particles with three different monoclonal antibodies raised against BoNT/E revealed the positions of their epitopes in the EM structure, thereby identifying the three hallmark domains of BoNT (protease, translocation and receptor binding). Correspondingly, these antibodies selectively inhibit BoNT translocation activity as detected using a single-molecule assay. The global structure of BoNT/E is strikingly different from that of BoNT/A despite strong sequence similarity. We postulate that the unique architecture of functionally conserved modules underlies the distinguishing attributes of BoNT/E and contributes to differences with BoNT/A.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Wang, J. Meng, G. W. Lawrence, T. H. Zurawski, A. Sasse, M. O. Bodeker, M. A. Gilmore, E. Fernandez-Salas, J. Francis, L. E. Steward, et al.
Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics
J. Biol. Chem., June 20, 2008; 283(25): 16993 - 17002.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.